RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Windtree Therapeutics Stock

Windtree Therapeutics Market capitalization 2024

Windtree Therapeutics Market capitalization

2.37 M USD

Ticker

WINT

ISIN

US97382D3035

WKN

A2P3ZQ

In 2024, Windtree Therapeutics's market cap stood at 2.37 M USD, a -96.38% increase from the 65.43 M USD market cap in the previous year.

The Windtree Therapeutics Market capitalization history

YEARMarket Capitalization (undefined USD)
2023206.47
202218.95
202165.36
2020126.75
2019128.66
201816.95
201714.77
201623.2
201559.39
2014141.75
2013153.02
2012198.57
2011-
2010-
2009-
2008-
2007-
2006-
2005-
2004-

Windtree Therapeutics Aktienanalyse

What does Windtree Therapeutics do?

Windtree Therapeutics is an emerging biotechnology company based in Pittsburgh, Pennsylvania. The company was founded in 2011 and specializes in the development of innovative therapies for respiratory diseases. Windtree Therapeutics aims to improve the lives of millions of people worldwide by providing effective and safe medications. History: Windtree Therapeutics has a history that dates back to 1990 when it was founded as Advanced Inhalation Research, focusing on the development of therapies for respiratory diseases. After several rounds of financing and mergers, the company was eventually revived as Windtree Therapeutics. Since then, the company has developed and marketed a range of innovative therapies that improve the lives of millions of patients with respiratory diseases. Business model: Windtree Therapeutics is a biotechnology company focused on the development and commercialization of therapies for respiratory diseases. The company has a strong ethos for innovation and works closely with leading medical and scientific experts to develop high-quality and safe products. The company holds a variety of patents and unique technologies that allow it to improve its competitive position in the industry. Segments: Windtree Therapeutics operates in two business segments: PneumRX® Bronchial Tubes and KL4-Surfactant Technology. PneumRX® Bronchial Tubes: One of Windtree Therapeutics' main segments is the PneumRX® Bronchial Tube technology. This technology aims to improve the lives of patients with chronic obstructive pulmonary disease (COPD). The PneumRX® tubes are used as minimally invasive procedures to open the lumen of the bronchial tubes and facilitate breathing. The technology has already been used in thousands of patients worldwide and is highly regarded by physicians. KL4-Surfactant Technology: Windtree Therapeutics is also known for its KL4-Surfactant Technology, which aims to treat respiratory distress syndrome in newborns. The company has already conducted a number of clinical studies, and the results have been very promising. The KL4-Surfactant Technology is considered one of the most promising treatment options for respiratory problems in newborns. Products: Windtree Therapeutics has a range of products on the market, including: Aer-OS Nitric Oxide Inhalation Device: The Aer-OS Nitric Oxide Inhalation Device is a medical device for patients with pulmonary hypertension. It is the first and only portable nitric oxide inhalation device approved for use at home and on-the-go. The device is used to facilitate breathing and improve patients' quality of life. PneumRX® Bronchial Tubes: The PneumRX® Bronchial Tube technology has already been performed in thousands of patients and is highly regarded by physicians. The technology aims to open the lumen of the bronchial tubes and facilitate breathing. The procedures are minimally invasive and result in minimal injuries. Patients often experience significant improvement in their breathing and overall well-being. KL4-Surfactant Technology: Windtree Therapeutics' KL4-Surfactant Technology is a promising treatment option for respiratory problems in newborns. The technology aims to stimulate lung growth and facilitate breathing. The results of clinical studies have been very promising, and the treatment is considered one of the most promising treatment options for respiratory problems in newborns. In conclusion, Windtree Therapeutics is an emerging biotechnology company with a strong ethos for innovation and the development of therapies for respiratory diseases. The PneumRX® Bronchial Tube technology and KL4-Surfactant Technology are two of the company's main segments. Both technologies are promising and have the potential to improve the lives of millions of patients worldwide. Windtree Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Windtree Therapeutics's Market Capitalization

Windtree Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Windtree Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Windtree Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Windtree Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Windtree Therapeutics stock

What is the current Windtree Therapeutics market capitalization?

The current market capitalization of Windtree Therapeutics is 2.37 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Windtree Therapeutics.

How has the market capitalization of Windtree Therapeutics developed in recent years?

The market capitalization of Windtree Therapeutics has increased/decreased by -96.38% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Windtree Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Windtree Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Windtree Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Windtree Therapeutics pay?

Over the past 12 months, Windtree Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Windtree Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Windtree Therapeutics?

The current dividend yield of Windtree Therapeutics is .

When does Windtree Therapeutics pay dividends?

Windtree Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Windtree Therapeutics?

Windtree Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Windtree Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Windtree Therapeutics located?

Windtree Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Windtree Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Windtree Therapeutics from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Windtree Therapeutics pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Windtree Therapeutics in the year 2023?

In the year 2023, Windtree Therapeutics distributed 0 USD as dividends.

In which currency does Windtree Therapeutics pay out the dividend?

The dividends of Windtree Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Windtree Therapeutics

Our stock analysis for Windtree Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Windtree Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.